FBT First Trust NYSE Arca Biotechnology Index Fund
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) designed with a clear purpose: to accurately reflect the price movements and income generated by the NYSE Arca Biotechnology Index. Its core objective is to closely match the performance of this benchmark index, before accounting for the fund's operational fees and expenses.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| FBT | +4.4% | +5.9% | +31.3% | +35.8% | +26.1% | +11.2% |
| Sector Equity average (79 funds) | -1.3% | -4.1% | +12.7% | +14.3% | +15.8% | +5.2% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$831K net.
Holdings · as of Nov 12, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | GMAB Genmab A/S (ADR) | 4.68% |
| 2 | REGN Regeneron Pharmaceuticals, Inc. | 4.14% |
| 3 | ADMA ADMA Biologics, Inc. | 4.10% |
| 4 | NBIX Neurocrine Biosciences, Inc. | 3.94% |
| 5 | TGTX TG Therapeutics, Inc. | 3.83% |
| 6 | ARGX argenx SE (ADR) | 3.82% |
| 7 | ONC BeOne Medicines Ltd. (ADR) | 3.82% |
| 8 | EXEL Exelixis, Inc. | 3.80% |
| 9 | ALKS Alkermes Plc | 3.80% |
| 10 | AMGN Amgen Inc. | 3.63% |
| 11 | GILD Gilead Sciences, Inc. | 3.62% |
| 12 | BIIB Biogen Inc. | 3.62% |
| 13 | UTHR United Therapeutics Corporation | 3.49% |
| 14 | INCY Incyte Corporation | 3.49% |
| 15 | VRTX Vertex Pharmaceuticals Incorporated | 3.45% |
| 16 | BMRN BioMarin Pharmaceutical Inc. | 3.43% |
| 17 | BRKR Bruker Corporation | 3.42% |
| 18 | TARS Tarsus Pharmaceuticals, Inc. | 3.38% |
| 19 | NEO NeoGenomics, Inc. | 3.32% |
| 20 | TECH Bio-Techne Corporation | 3.24% |
| 21 | RGEN Repligen Corporation | 3.20% |
| 22 | HALO Halozyme Therapeutics, Inc. | 2.97% |
| 23 | MDGL Madrigal Pharmaceuticals, Inc. | 2.96% |
| 24 | BNTX BioNTech SE (ADR) | 2.91% |
| 25 | AXSM Axsome Therapeutics, Inc. | 2.86% |
| 26 | NTRA Natera, Inc. | 2.57% |
| 27 | ILMN Illumina, Inc. | 2.47% |
| 28 | ALNY Alnylam Pharmaceuticals, Inc. | 2.21% |
| 29 | CORT Corcept Therapeutics Inc. | 1.98% |
| 30 | VCYT Veracyte, Inc. | 1.79% |
| 31 | FBT US Dollar | 0.09% |
Sector breakdown
Country breakdown
Distributions
| Date | Per unit |
|---|---|
| Dec 13, 2024 | $1.1726 |
| Dec 30, 2021 | $2.2140 |
| Sep 23, 2015 | $0.0200 |
| Jun 24, 2015 | $0.0650 |
| Mar 25, 2015 | $0.0480 |
| Dec 23, 2014 | $0.0524 |
| Jun 23, 2008 | $0.2697 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in FBT in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error